z-logo
open-access-imgOpen Access
miR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells
Author(s) -
Bin Fu,
Yibing Wang,
Xiali Zhang,
Bin Lang,
Xiaocheng Zhou,
Xiaoyuan Xu,
Tao Zeng,
Weipeng Liu,
Xu Zhang,
Ju Guo,
Gongxian Wang
Publication year - 2015
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2015.2837
Subject(s) - puma , apoptosis , cancer research , biology , cancer cell , immune system , transfection , oncogene , bladder cancer , gene silencing , cancer , signal transduction , cell cycle , microbiology and biotechnology , immunology , cell culture , gene , biochemistry , genetics
Immune evasion of cancer cells is mainly due to the impaired transduction of apoptotic signals from immune cells to cancer cells, as well as inhibition of subsequent apoptosis signal cascades within the cancer cells. Over the past few decades, the research has focused more on the impaired transduction of the apoptotic signal from immune cells to cancer cells, rather than inhibition of the intracellular signaling pathways. In this study, miR‑221 inhibitor was transfected into bladder cancer cell lines 5637, J82 and T24 to repress the expression of miR‑221. As a result, the repression of miR‑221 on p53 upregulated modulator of apoptosis (PUMA) was abolished, resulting in increased expression of the pro-apoptotic Bax and reduced expression of the anti-apoptotic Bcl-2, which promotes apoptosis of bladder cancer cells. The expression of MMP-2, MMP-9 and VEGF-C were reduced, resulting in reduced invasiveness and infiltration capability of bladder cancer cells, thereby inhibiting the immune evasion of bladder cancer cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom